Life Sciences News

Strength of Life Sciences Lifts Philly’s VC Ecosystem to Record Heights

February 18, 2020

At $2.5 billion invested across 225 venture financings for the year, Philly’s venture ecosystem closed out 2019 stronger than ever, helping to push the average disclosed round value to $11.2 million. Moreover, the region’s pharma & biotech sector commanded more than $1 billion in overall deal value in its own right last year for the […]

Clean Energy Jobs are Truly ‘Made in Pennsylvania’

September 26, 2018

When Pennsylvanians think of clean energy jobs, the images that come to mind might include a team of solar installers drilling panels onto a roof in Bucks County, or a hard-hatted wind turbine technician perched atop a 200-foot-tall white tower at Moosic Mountain outside Scranton. High-flying, high-profile jobs like these are crucial to our state’s […]

Philly Now a Top 5 City for Life Sciences, Study Says

July 21, 2017

Professional services and research firm JLL recently released its annual Life Sciences Outlook report, which scores 15 metropolitan areas across the country and Canada on life sciences workforce statistics, funding availability, and other factors. The report reinforces the idea that Philadelphia’s life sciences industry is thriving. The city came in at #5 on the list, […]

The One Health Company Featured at The World Economic Forum

January 31, 2017

Christina Lopes, the CEO and co-founder of The One Health Company, got a unique opportunity to raise the profile of her Philadelphia life science startup with an appearance at the World Economic Forum in Davos, Switzerland in January 2017. A Young Global Leaders of World Economic Forum alumnus, Lopes was invited to attend the World Economic Forum […]

Technology Trends We’d Like to See More of in 2017

January 26, 2017

We live in a world where new technology is constantly and consistently advancing and new companies are born every day. In 2014, the recession maintained its grasp on American ingenuity as entrepreneurship hit a 20-year low. However, according to the Kauffman Index for 2016, startup activity rebounded last year, going up for the second year in […]

MBF Therapeutics Teams Up With Wistar

December 1, 2016

A Montgomery County company seeking to develop ways to treat cancer in dogs and cats has secured a new partner and new investment to help it achieve its goals. MBF Therapeutics of Ambler raised more than $100,000 in new capital from private investors and converted existing debt and notes into equity in a $1.1 million […]

Essential Medical Inc. Announces Successful Live Case at TCT

November 8, 2016

Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today the first live MANTA case at the Transcatheter Therapeutics conference (TCT) in Washington DC. TCT is the largest annual interventional cardiology conference in North America. The case was performed live on Monday October 31st by […]

QR Pharma Raises $800,000 of Series A Preferred Stock

October 28, 2016

QR Pharma, Inc., a privately held biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s, Parkinson’s and other neurodegenerative diseases, has closed on $800,000 of Series A Preferred Stock financing. Existing investors Robin Hood Ventures and individual angels filled this round. QR Pharma will use the funding to continue to develop its lead compound, […]

ZSX Medical wins $100K at angel group Keiretsu Forum’s annual expo

October 28, 2016

ZSX Medical, a medical device company based out of a life sciences coworking space on Drexel’s campus, won the top prize — a $100,000 investment — at the Keiretsu Forum Mid-Atlantic’s fourth annual Angel Capital Expo on Wednesday. At the angel group’s expo, held at Drexel University’s Bossone Research Center, 15 companies pitched. Following the […]

FDA Approves Janssen Biotech’s Drug for Crohn’s Disease

September 30, 2016

The Food and Drug Administration approved expanding the label for Horsham-based Janssen Biotech’s Stelara product to include its use for the treating Crohn’s disease. Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract that affects about 700,000 Americans. The FDA approval of Stelara specified its use in adults 18 or older with moderately […]